memori
b
cell
repres
repositori
immun
experi
individu
select
germin
centr
undergo
process
somat
mutat
select
antigen
helper
cell
memori
b
cell
persist
life
time
rapidli
respond
booster
immun
gener
larg
number
plasma
cell
transient
present
blood
local
surviv
nich
bone
marrow
plasma
cell
main
sourc
serum
antibodi
interrog
memori
b
cell
plasma
cell
repertoir
human
offer
uniqu
opportun
compar
mice
human
natur
expos
pathogen
often
recurr
infect
therefor
better
sourc
antibodi
target
relev
antigen
reveal
mechan
interact
furthermor
given
genet
variabl
human
popul
idiosyncrasi
immun
respons
individu
may
gener
antibodi
unusu
potenc
breadth
final
studi
antibodi
respons
human
shed
light
basic
aspect
immun
respons
role
somat
mutat
mechan
underpin
gener
broadli
neutral
antibodi
autoantibodi
possibl
uncov
exampl
mechan
may
uniqu
develop
better
identifi
human
last
decad
sever
method
develop
isol
human
monoclon
antibodi
principl
come
two
basic
approach
first
approach
consist
isol
singl
b
cell
use
fluoresc
tag
antigen
bait
follow
clone
immunoglobulin
gene
express
recombin
antibodi
cell
line
method
effect
requir
target
antigen
known
avail
purifi
form
laboratori
develop
altern
approach
base
screen
antibodi
produc
cultur
b
cell
plasma
cell
fig
memori
b
cell
select
donor
immort
high
effici
combin
viru
deliv
signal
signal
agonist
deliv
signal
requir
potent
activ
memori
b
cell
traggiai
et
al
immort
b
cell
prolifer
secret
larg
amount
antibodi
cultur
supernat
plasma
cell
recov
follow
booster
immun
lost
prolif
capac
kept
aliv
cultur
supplement
stromal
cell
cultur
mimic
surviv
nich
bone
marrow
singl
plasma
cell
secret
antibodi
constant
rate
pgday
corti
et
al
facilit
isol
specif
antibodi
clone
vhvl
gene
immort
b
cell
plasma
cell
seed
clonal
condit
cultur
handl
autom
liquid
handl
system
distinct
advantag
screen
repertoir
secret
antibodi
first
approach
sinc
screen
done
use
function
assay
viru
neutral
without
priori
knowledg
target
antigen
use
even
whole
bacteria
parasit
second
well
suit
identifi
antibodi
differ
antigen
sinc
parallel
screen
perform
multipl
target
third
bypass
need
sequenc
express
larg
number
antibodi
sequenc
sinc
cell
interest
select
base
initi
screen
relev
exampl
util
approach
come
studi
antibodi
respons
human
cytomegaloviru
hcmv
complex
herpesviru
express
differ
surfac
glycoprotein
caus
seriou
patholog
foetu
immunocompromis
patient
screen
capac
neutral
viru
isol
antibodi
potent
antibodi
fusion
protein
gb
identifi
viral
target
pentamer
complex
form
gh
gl
produc
solubl
form
pentam
found
elicit
mice
neutral
antibodi
titr
exceed
induc
human
natur
infect
kabanova
et
al
studi
illustr
gener
approach
analyt
vaccinolog
neutral
antibodi
use
identif
target
antigen
qualiti
control
recombin
vaccin
possibl
perform
parallel
screen
multipl
target
instrument
identif
broadli
reactiv
antibodi
capabl
neutral
multipl
virus
includ
antibodi
bind
conserv
epitop
stem
region
influenza
hemagglutinin
ha
neutral
influenza
virus
corti
et
al
kallewaard
et
al
antibodi
bind
uniqu
conserv
site
form
f
protein
neutral
four
differ
paramyxovirus
includ
human
rsv
mpv
corti
et
al
antibodi
promis
candid
prophylaxi
therapi
infect
sinc
trigger
effector
function
target
conserv
structur
thu
limit
possibl
select
escap
mutant
addit
repres
use
tool
design
stabil
glycoprotein
vaccin
straightforward
applic
method
lie
rapid
isol
neutral
antibodi
emerg
pathogen
ebola
viru
sar
traggiai
et
al
mer
coronavirus
case
mer
possibl
month
go
sampl
memori
b
cell
preclin
valid
neutral
antibodi
gener
cell
line
produc
antibodi
gramsl
amount
similar
studi
dengu
zika
virus
defin
differ
class
antibodi
endow
neutral
activ
interrog
memori
repertoir
offer
opportun
investig
biolog
medic
relev
set
fundament
aspect
human
immun
respons
rel
contribut
germ
line
polymorph
vdj
junction
divers
somat
mutat
antigen
specif
interest
exampl
come
studi
antibodi
neutral
group
influenza
virus
produc
individu
follow
infect
vaccin
report
sever
laboratori
public
antibodi
use
bind
exclus
vh
conserv
region
ha
stem
isol
larg
number
sister
clone
perform
genealog
analysi
differ
clonal
famili
found
unmut
common
ancestor
uca
low
affin
group
ha
neutral
infect
fig
c
remark
first
branch
point
acquir
singl
mutat
high
affin
neutral
activ
compar
antibodi
isol
memori
b
cell
carri
amino
acid
substitut
pappa
et
al
find
demonstr
affin
matur
achiev
rapidli
singl
mutat
numer
redund
somat
mutat
continu
accumul
provid
extens
diversif
within
prolifer
clone
interestingli
antibodi
critic
contact
residu
posit
dimorph
differ
allel
carri
either
f
l
consequ
individu
lack
allel
produc
public
antibodi
respons
individu
allel
high
frequenc
precursor
addit
requir
acid
make
critic
contact
site
antigen
find
underlin
impact
polymorph
antibodi
respons
suggest
certain
allel
may
play
role
immun
respons
ir
gene
becom
posit
select
popul
expos
given
pathogen
genealog
analysi
two
neutral
antibodi
show
correspond
uca
alreadi
high
bind
affin
neutral
activ
group
virus
acquir
capac
neutral
group
virus
somat
mutat
kallewaard
et
al
find
consist
model
neutral
antibodi
aris
prime
precursor
group
viru
case
follow
somat
mutat
gener
variant
broader
reactiv
group
virus
boost
group
viru
fig
importantli
isol
cell
produc
ident
antibodi
consecut
year
respons
vaccin
infect
indic
secondari
antibodi
respons
larg
extent
independ
germin
centr
factor
allow
antibodi
retain
origin
specif
genealog
analysi
neutral
antibodi
reveal
similar
mechan
uca
possess
high
affin
rsv
acquir
mpv
somat
mutat
corti
et
al
extens
antibodi
diversif
observ
human
increas
antibodi
affin
promot
breadth
come
price
gener
mani
new
specif
may
notion
autoantibodi
gener
somat
mutat
support
human
find
uca
autoantibodi
specif
desmoglein
found
patient
sever
autoimmun
diseas
bind
respect
di
zenzo
et
al
piccoli
et
al
thu
tempt
specul
autoantibodi
may
gener
somat
mutat
clone
respons
foreign
antigen
absenc
structur
mimicri
importantli
mechan
delet
anergi
restrain
autoreact
b
cell
may
appli
activatedmemori
b
cell
differ
trigger
requir
traffic
peripher
tissu
mention
approach
especi
suit
dissect
antibodi
respons
complex
pathogen
absenc
detail
knowledg
target
antigen
interest
identifi
antibodi
could
broadli
recogn
variant
surfac
antigen
vsa
plasmodium
falciparum
parasit
caus
malaria
express
surfac
infect
erythrocyt
i
vsa
mediat
adhes
i
endothelia
target
antibodi
control
diseas
high
number
gene
extens
polymorph
clonal
express
provid
pathogen
power
escap
strategi
larg
kenyan
cohort
initi
select
two
individu
serum
antibodi
erythrocyt
infect
differ
p
falciparum
strain
memori
b
cell
isol
panel
broadli
reactiv
monoclon
antibodi
use
stain
infect
erythrocyt
screen
strategi
surprisingli
broadli
reactiv
antibodi
uniqu
structur
sinc
carri
larg
insert
v
dj
segment
insert
approxim
bp
compris
exon
encod
extracellular
domain
inhibitori
receptor
encod
leucocyt
receptor
cluster
chr
tan
et
al
given
insert
v
dj
domain
posit
tip
fig
b
target
antigen
antibodi
identifi
member
rifin
famili
polymorph
vsa
express
surfac
i
fig
importantli
insert
domain
necessari
suffici
bind
rifin
demonstr
insert
irrelev
antibodi
product
fusion
protein
investig
frequent
antibodi
produc
screen
two
addit
cohort
mali
tanzania
found
individu
antibodi
serum
pieper
et
al
studi
led
isol
monoclon
antibodi
also
find
new
insert
modal
exon
intron
sequenc
insert
immunoglobulin
switch
region
insert
lead
exon
shuffl
product
origin
antibodi
bispecif
antibodi
contain
domain
precis
place
elbow
vh
domain
fig
b
one
case
insert
switch
region
accompani
genom
delet
vh
gener
antibodi
individu
analys
far
antibodi
domin
respons
i
produc
singl
clone
contain
uniqu
insert
undergo
extens
expans
somat
mutat
thu
demonstr
extraordinari
fit
somat
mutat
frequent
insert
junction
continu
target
aid
germin
centr
less
frequent
insert
switch
region
transient
target
aid
switch
recombin
interestingli
somat
mutat
domain
elimin
collagen
bind
modul
affin
differ
rifin
find
collagen
bind
alway
lost
even
somat
mutat
mechan
less
effect
suggest
loss
prerequisit
expans
b
cell
make
antibodi
insert
sequenc
encod
structur
domain
ig
gene
new
potenti
gener
concept
find
facilit
huge
expans
b
cell
uniqu
properti
antibodi
made
initi
attempt
determin
gener
phenomenon
found
frequent
insert
switch
region
memori
b
cell
european
blood
donor
interestingli
insert
larg
origin
gene
transcrib
b
cell
encod
virtual
chromosom
rare
case
compris
exon
frame
compat
express
fig
malaria
infect
caus
chromosom
instabl
transloc
involv
switch
region
suggest
may
also
play
caus
role
gener
templat
insert
howev
find
frequent
templat
insert
european
blood
donor
consist
gener
mechan
remain
molecularli
defin
site
insert
suggest
mechan
dna
break
induc
either
rag
aid
recombin
class
switch
integr
genom
loci
clone
produc
antibodi
suggest
mechan
view
find
insert
contain
intron
sequenc
deriv
express
gene
favour
hypothesi
templat
dna
may
origin
resolut
stall
replic
fork
caus
clash
transcript
dna
replic
find
suggest
insert
templat
dna
repres
novel
gener
mechan
antibodi
diversif
provid
broad
rang
protein
domain
diversifi
somat
mutat
exemplifi
insert
domain
encod
pathogen
receptor
gener
public
antibodi
effect
pathogen
distinct
advantag
antibodi
lie
broad
recognit
pathogen
variant
leav
room
select
escap
mutant
possibl
diversifi
receptor
domain
somat
mutat
increas
bind
pathogen
decreas
new
antibodi
reminisc
ehrlich
theori
antibodi
product
antibodi
essenti
secret
form
receptor
pathogen
predict
exampl
antibodi
found
respons
varieti
human
pathogen
besid
candid
gener
antibodi
p
falciparum
adhes
molecul
bind
i
inhibitori
receptor
like
shown
bind
rifin
similarli
insert
slam
domain
may
gener
antibodi
neutral
rhinovirus
measl
viru
final
remark
realiz
uncov
ingenu
natur
learn
new
way
engin
antibodi
possibl
edit
antibodi
primari
b
cell
use
endogen
aid
activ
also
discov
strong
antibodi
respons
gener
singl
clone
rais
case
adopt
therapi
al
scientif
founder
humab
biom
substanti
interest
antibodi
develop
humab
sharehold
vir
bio
